UBS Group »

Jade Biosciences shares owned by UBS Group

Quarter-by-quarter ownership of Jade Biosciences (JBIO) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Jade Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Jade Biosciences held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jade Biosciences by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $171k 20k 8.63
2025-06-30 $210k 21k 9.99

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Jade Biosciences

FMR
Fairmount Funds Management
VR Adviser
Deep Track Capital
BlackRock
Vanguard Group
Versant Venture Management
Rtw Investments
Frazier Life Sciences Management
Driehaus Capital Management
Avidity Partners Management
RA Capital Management
Soleus Capital Management
Geode Capital Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Jade Biosciences